Technical Analysis for NURO - NeuroMetrix, Inc.

Grade Last Price % Change Price Change
C 4.00 -0.36% -0.01
NURO closed down 0.36 percent on Friday, November 1, 2024, on 2.78 times normal volume. It ran into resistance at its 50 day moving average. The bulls were able to push the stock to a new 52-week high. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
50 DMA Resistance Bearish 0.00%
MACD Bearish Centerline Cross Bearish 0.00%
Shooting Star Candlestick Bearish 0.00%
Lizard Bearish Bearish Day Trade Setup 0.00%
Calm After Storm Range Contraction 0.00%
Wide Range Bar Range Expansion 0.00%
Doji - Bearish? Reversal 0.00%
New 52 Week High Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%

   Recent Intraday Alerts

Alert Time
50 DMA Resistance about 18 hours ago
20 DMA Resistance about 18 hours ago
10 DMA Resistance about 18 hours ago
3x Volume Pace about 19 hours ago
Upper Bollinger Band Resistance about 19 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

NeuroMetrix, Inc. Description

NeuroMetrix, Inc., a medical device company, develops and markets products for the detection, diagnosis, and monitoring of peripheral nerve and spinal cord disorders, such as those associated with carpal tunnel syndrome, lumbosacral disc disease, spinal stenosis, and diabetes. The company focuses on the diagnosis and treatment of neurological complications of diabetes, including diabetic peripheral neuropathy (DPN) and median neuropathy. Its marketed products include NC-stat DPNCheck, a device used to evaluate systemic neuropathies, such as DPN at the point-of-care; SENSUS pain therapy device, a transcutaneous electrical nerve stimulator used for chronic and intractable pain relief; and ADVANCE NCS/EMG system, a platform for the performance of traditional nerve conduction studies and invasive electromyography procedures for the assesment of CTS, low back and leg pain, and DPN, as well as consumables and accessories. The company is also developing SENTINEL device that provides sensory enhancement in the feet targeted at patients who have lost sensory perception in the lower extremities. NeuroMetrix, Inc. distributes its products directly through its direct sales force and independent sales representatives to physicians, clinics, hospitals, managed care organizations, retail health businesses, and independent distributors consisting of primary care, internal medicine, orthopedic and hand surgeons, pain medicine physicians, neurologists, physical medicine and rehabilitation, physicians, and neurosurgeons, as well as endocrinology and podiatry markets primarily in the United States, the United Kingdom, the Netherlands, and India. The company was founded in 1996 and is headquartered in Waltham, Massachusetts.


Classification

Sector: Healthcare
Industry: Medical Instruments & Supplies
Keywords: Medicine Pain Diabetes Clinic Neuroscience Pain Management Neuromodulation Neurophysiology Neurotechnology Primary Care Acute Pain Managed Care Nerve Nervous System Endocrinology Podiatry Electrodiagnosis Spinal Cord Peripheral Neuropathy Diabetic Peripheral Neuropathy Sensus Carpal Tunnel Carpal Tunnel Syndrome Physical Medicine And Rehabilitation Spinal Cord Disorders Spinal Stenosis Transcutaneous Electrical Nerve Stimulation

Is NURO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 4.73
52 Week Low 2.66
Average Volume 17,671
200-Day Moving Average 3.80
50-Day Moving Average 4.04
20-Day Moving Average 4.20
10-Day Moving Average 4.15
Average True Range 0.30
RSI (14) 44.44
ADX 15.88
+DI 26.44
-DI 18.65
Chandelier Exit (Long, 3 ATRs) 3.82
Chandelier Exit (Short, 3 ATRs) 4.71
Upper Bollinger Bands 4.62
Lower Bollinger Band 3.79
Percent B (%b) 0.25
BandWidth 19.80
MACD Line 0.00
MACD Signal Line 0.05
MACD Histogram -0.0552
Fundamentals Value
Market Cap 4.37 Million
Num Shares 1.09 Million
EPS -5.60
Price-to-Earnings (P/E) Ratio -0.71
Price-to-Sales 0.55
Price-to-Book 0.18
PEG Ratio -0.01
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.22
Resistance 3 (R3) 5.33 5.03 5.02
Resistance 2 (R2) 5.03 4.72 4.98 4.95
Resistance 1 (R1) 4.52 4.53 4.37 4.41 4.88
Pivot Point 4.22 4.22 4.14 4.16 4.22
Support 1 (S1) 3.70 3.90 3.55 3.59 3.12
Support 2 (S2) 3.40 3.71 3.35 3.05
Support 3 (S3) 2.89 3.40 2.98
Support 4 (S4) 2.78